Although the disruption of ANX2/p11 interaction reduced ALL cell binding to osteoblasts, and homing and engraftment of ALL cells in the bone marrow, there was no complete abolishment of these effects. The gene discussed is ANXA2; the disease is acute lymphoblastic leukemia.